SCHEMBL24695405

SCHEMBL24695405

COc1cc(C(F)(F)F)cc(C)c1-c1cnc(N)nn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 3/20 0.40
▸ FEN1 P39748 3/20 0.40
▸ IL1B P01584 3/20 0.36
▸ PDE2A O00408 3/20 0.36
▸ PDE10A Q9Y233 3/20 0.36
▸ PDE6D O43924 2/20 0.36
▸ PDE6A P16499 2/20 0.36
▸ PDE6G P18545 2/20 0.36
▸ PDE6B P35913 2/20 0.36
▸ PDE6C P51160 2/20 0.36
▸ PDE6H Q13956 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ METAP2 P50579 1/20 0.36
▸ DHFR P00374 3/20 0.34
▸ TNF P01375 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.33
▸ CRHR1 P34998 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26093443 0.83 ALOX5AP (0.36) ALOX5APFEN1IL1BTNFNLRP3
SCHEMBL24695709 0.81 IL1B (0.51) IL1BTNFNLRP3
SCHEMBL31624816 0.73 PDE2A (0.34) ALOX5APFEN1IL1BPDE2APDE10A
SCHEMBL31624801 0.73 PDE2A (0.35) ALOX5APFEN1IL1BPDE2APDE10A
SCHEMBL31553142 0.70 PIK3CD (0.35) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL30951395 0.69 AGPAT2 (0.35) IL1BPDE2APDE10APDE6DPDE6A
SCHEMBL30375350 0.68 IL1B (0.35) IL1BTNFNLRP3
SCHEMBL26093672 0.68 IL1B (0.35) IL1BTNFNLRP3
SCHEMBL30374854 0.67 SMN1; SMN2 (0.39) ALOX5APFEN1CYP1A2DHFRCRHR1
SCHEMBL26089911 0.67 SMN1; SMN2 (0.39) ALOX5APFEN1CYP1A2DHFRCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253936-A1 TRIAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER. F. HOFFMANN-LA ROCHE AG (CH) 2022-12-08 — — WO disclosed
Send feedback